Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Jing-dong Li"'
Autor:
Kong-Ying Lin, Jian-Xi Zhang, Zhi-Wen Lin, Qing-Jing Chen, Liu-Ping Luo, Jin-Hong Chen, Kui Wang, Sheng Tai, Zhi-Bo Zhang, Shi-Feng Wang, Jing-Dong Li, Kai Wang, Lu Zheng, Si-Ming Zheng, Meng-Meng Wu, Ke-Can Lin, Tian Yang, Yong-Yi Zeng
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThis study evaluates the efficacy of alpha-fetoprotein (AFP) response as a surrogate marker for determining recurrence-free survival (RFS) in patients with unresectable hepatocellular carcinoma (uHCC) who undergo salvage hepatectomy followi
Externí odkaz:
https://doaj.org/article/c94467943cf8482793fef503755d11c9
Autor:
Yi Zhou, Gang Yang, Xue-Qin Gong, Yun-Yun Tao, Ran Wang, Jing Zheng, Cui Yang, Juan Peng, Lin Yang, Jing-Dong Li, Xiao-Ming Zhang
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract The present study aimed to investigate the value of intravoxel incoherent motion diffusion weighted imaging (IVIM-DWI) in the preoperative prediction of the histologic differentiation of hepatocellular carcinoma (HCC). Seventy HCC patients w
Externí odkaz:
https://doaj.org/article/eedde51d957847b9b1adea81572a9360
Autor:
Xue-Qin Gong, Yun-Yun Tao, Yao–Kun Wu, Ning Liu, Xi Yu, Ran Wang, Jing Zheng, Nian Liu, Xiao-Hua Huang, Jing-Dong Li, Gang Yang, Xiao-Qin Wei, Lin Yang, Xiao-Ming Zhang
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundHepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third leading cause of cancer-related death. Although the diagnostic scheme of HCC is currently undergoing refinement, the prognosis of HCC is still not sat
Externí odkaz:
https://doaj.org/article/d8fdcf504310422fb356bc94bb85517d
Autor:
Zhan Yang, Jin-Suo Chen, Jin-Kun Wen, Hai-Tao Gao, Bin Zheng, Chang-Bao Qu, Kai-Long Liu, Man-Li Zhang, Jun-Fei Gu, Jing-Dong Li, Yan-Ping Zhang, Wei Li, Xiao-Lu Wang, Yong Zhang
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 36, Iss 1, Pp 1-15 (2017)
Abstract Background Docetaxel-based chemotherapy failure in advanced prostate carcinoma has partly been attributed to the resistance of prostate cancer (PC) cells to docetaxel-induced apoptosis. Hence, there is an urgent need to identify mechanisms o
Externí odkaz:
https://doaj.org/article/fbf294aeb114404cb53a07521614f8ed
Autor:
Le-bao Song, Dong Xu, Peng-fei Liu, Jin-hang Zhou, Hui-qing Yan, Jing-dong Li, Hai-nan He, Hai-jun Yu, Xiao-chen Wang, Quan Yang
Publikováno v:
Journal of Iron and Steel Research International. 30:960-970
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3d1589c928aad66b97857dc6d388839c
https://doi.org/10.1007/s42243-023-00935-3
https://doi.org/10.1007/s42243-023-00935-3
Autor:
Jing-dong Li, Tao Tang, Jie Zhou, Li-xin Zhang, Gang Yang, Wei-nan Li, Jian-jiao Zhu, Yong-fu Xiong
Publikováno v:
Anti-Cancer Agents in Medicinal Chemistry. 23
Purpose: To explore the possibility of a combination of dabrafenib and SHP2 inhibitor in the treatment of anaplastic thyroid carcinoma and to provide a new therapeutic strategy for the treatment of anaplastic thyroid cancer. Patients and Methods: Fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ae6823980493d9c6ba5d01d60633ab0
https://doi.org/10.2174/1871520623666230214093122
https://doi.org/10.2174/1871520623666230214093122
Publikováno v:
Journal of Iron and Steel Research International.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1b7eb5326790fc34b83a79a1f82b16a9
https://doi.org/10.1007/s42243-022-00894-1
https://doi.org/10.1007/s42243-022-00894-1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Jing Dong Li, Lei Wang, Xin Yu Bi, Jian Wang, Zi Guo Lin, Shi Cheng, Jian Ming Wang, Shu Guo Zheng, Yong Yi Zeng, Wei Guo, Qiao Ke, Jian Ying Lou, Ya Min Zheng, Wei Ping Zhou, Fu-Yu Li
Publikováno v:
Journal of Cancer
Background and Aims: The prognosis of intrahepatic cholangiocarcinoma (ICC) after radical resection is far from satisfactory, but the effect of postoperative transarterial chemoembolization (p-TACE) remains controversial. This multi-center retrospect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a0049da67dcd28873aea087f6aa852d3
https://doi.org/10.7150/jca.40358
https://doi.org/10.7150/jca.40358
Autor:
Gang Yang, Yao–Kun Wu, Jing-Dong Li, Jing Zheng, Ning Liu, Xiao-Ming Zhang, Xiao Hua Huang, Lin Yang, Ran Wang, Xiao-Qin Wei, Nian Liu, Yun-Yun Tao, Xi Yu, Xue-Qin Gong
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundHepatocellular carcinoma (HCC) is the sixth most common cancer in the world and the third leading cause of cancer-related death. Although the diagnostic scheme of HCC is currently undergoing refinement, the prognosis of HCC is still not sat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ec784e9449dc3563590906046a334c8
https://www.frontiersin.org/articles/10.3389/fonc.2021.698373/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.698373/full